Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression

被引:18
|
作者
Li, Yunkuo [1 ]
Pan, Yujie [1 ]
Zhao, Xiaodong [1 ]
Wu, Shouwang [1 ]
Li, Faping [1 ]
Wang, Yuxiong [1 ]
Liu, Bin [1 ]
Zhang, Yanghe [2 ]
Gao, Xin [1 ]
Wang, Yishu [2 ]
Zhou, Honglan [1 ]
机构
[1] First Hosp Jilin Univ, Dept Urol, Changchun 130021, Peoples R China
[2] Jilin Univ, Key Lab Pathobiol, Minist Educ, Changchun 130021, Peoples R China
基金
中国国家自然科学基金;
关键词
PPAR; Cancer; Metabolic reprogramming; Anticancer therapy; UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA; PPAR-ALPHA AGONIST; INSULIN-RESISTANCE; ADIPOSE-TISSUE; GAMMA ACTIVATION; GENE-EXPRESSION; HEPATOMA-CELLS; PROFILING REVEALS; BREAST-CANCER; C666-1; CELLS;
D O I
10.1016/j.clnu.2023.12.005
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Lipids represent the essential components of membranes, serve as fuels for high-energy processes, and play crucial roles in signaling and cellular function. One of the key hallmarks of cancer is the reprogramming of metabolic pathways, especially abnormal lipid metabolism. Alterations in lipid uptake, lipid desaturation, de novo lipogenesis, lipid droplets, and fatty acid oxidation in cancer cells all contribute to cell survival in a changing microenvironment by regulating feedforward oncogenic signals, key oncogenic functions, oxidative and other stresses, immune responses, or intercellular communication. Peroxisome proliferator-activated receptors (PPARs) are transcription factors activated by fatty acids and act as core lipid sensors involved in the regulation of lipid homeostasis and cell fate. In addition to regulating whole-body energy homeostasis in physiological states, PPARs play a key role in lipid metabolism in cancer, which is receiving increasing research attention, especially the fundamental molecular mechanisms and cancer therapies targeting PPARs. In this review, we discuss how cancer cells alter metabolic patterns and regulate lipid metabolism to promote their own survival and progression through PPARs. Finally, we discuss potential therapeutic strategies for targeting PPARs in cancer based on recent studies from the last five years.(c) 2023 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:332 / 345
页数:14
相关论文
共 50 条
  • [41] Peroxisome proliferator-activated regulation of lipid metabolism by receptor α is involved in the ginseng
    Yoon, M
    Lee, H
    Jeong, S
    Kim, JJ
    Nicol, CJ
    Nam, KW
    Kim, M
    Cho, BG
    Oh, GT
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (07) : 1295 - 1302
  • [42] Lipid metabolism: peroxisome-proliferator-activated receptors and the regulation of genes of lipid metabolism
    Poisson, JP
    Narce, M
    CURRENT OPINION IN LIPIDOLOGY, 2001, 12 (05) : 583 - 584
  • [43] Peroxisome proliferator-activated receptors and renal diseases
    Wu, Jing
    Chen, Lihong
    Zhang, Dongjuan
    Huo, Ming
    Zhang, Xiaoyan
    Pu, Dan
    Guan, Youfei
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 : 995 - 1009
  • [44] Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis
    Vanden Heuvel, JP
    TOXICOLOGICAL SCIENCES, 1999, 47 (01) : 1 - 8
  • [45] Osteoarthritis: Role of Peroxisome Proliferator-Activated Receptors
    Sheng, Weibei
    Wang, Qichang
    Qin, Haotian
    Cao, Siyang
    Wei, Yihao
    Weng, Jian
    Yu, Fei
    Zeng, Hui
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [46] Peroxisome proliferator-activated receptors: good and bad
    Staels, B.
    CHEMISTRY AND PHYSICS OF LIPIDS, 2008, 154 : S15 - S16
  • [47] Peroxisome proliferator-activated receptors and shock state
    Esposito, Emanuela
    Cuzzocrea, Salvatore
    Meli, Rosaria
    THESCIENTIFICWORLDJOURNAL, 2006, 6 : 1770 - 1782
  • [48] Role of peroxisome proliferator-activated receptors in osteoarthritis
    Huang, Gang
    Jiang, Wei
    Xie, Weiyong
    Lu, Wei
    Zhu, Weimin
    Deng, Zhenhan
    MOLECULAR MEDICINE REPORTS, 2021, 23 (02)
  • [49] Peroxisome proliferator-activated receptors and skin development
    Rosenfield, RL
    Deplewski, D
    Greene, ME
    HORMONE RESEARCH, 2000, 54 (5-6) : 269 - 274
  • [50] Peroxisome proliferator-activated receptors and the cardiovascular system
    Chen, YQE
    Fu, MG
    Zhang, JF
    Zhu, XJ
    Lin, YM
    Akinbami, MA
    Song, Q
    VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 66, 2003, 66 : 157 - 188